Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol
Abstract Merck KGaA observed slight differences in the dissolution of Concor® (bisoprolol) batches over the years. The purpose of this work was to assess the impact of in vitro dissolution on the simulated pharmacokinetics of bisoprolol using in vitro-in vivo relationship established with available...
Saved in:
Main Authors: | Joyce S. Macwan (Author), Grace Fraczkiewicz (Author), Mauro Bertolino (Author), Phillip Krüger (Author), Sheila‐Annie Peters (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process
by: Edilainy Rizzieri Caleffi‐Marchesini, et al.
Published: (2024) -
In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
by: Tuba Incecayir, et al.
Published: (2023) -
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
by: Isabel Gonzalez-Alvarez, et al.
Published: (2024) -
Influence of immediate release tablet formulation on dissolution profile of paracetamol
by: Todorović Nemanja B., et al.
Published: (2018) -
Impact of Tablet Shape on Drug Dissolution Rate Through Immediate Released Tablets
by: Fatima Molavi, et al.
Published: (2020)